Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues: |
Title | 7,585.0 | 8,275.0 | 9,106.0 | 10,289.0 | 10,919.0 | 11,361.0 | 11,497.0 | 11,479.0 |
Corporate and Other | 155.0 | 130.0 | 111.0 | 101.0 | 131.0 | 176.0 | 184.0 | 202.0 |
Total revenues [+] | 1,974.0 | 2,097.0 | 2,272.0 | 2,460.0 | 2,640.0 | 2,753.0 | 2,821.0 | 2,819.0 |
Net investment income | 2,179.0 | 2,024.0 | 1,891.0 | 1,889.0 | 1,986.0 | 2,037.0 | 1,961.0 | 1,783.0 |
Revenue growth [+] | -25.2% | -23.8% | -19.5% | -12.7% | -3.9% | 6.6% | 17.6% | 22.9% |
Title | -30.5% | -27.2% | -20.8% | -10.4% | -1.1% | 10.6% | 22.6% | 32.8% |
Corporate and Other | 18.3% | -26.1% | -39.7% | -50.0% | -37.0% | -21.4% | | |
Cost of goods sold | 2,962.0 | 3,046.0 | 3,192.0 | 3,390.0 | 3,488.0 | 3,539.0 | 3,528.0 | 3,459.0 |
Gross profit | -988.0 | -949.0 | -920.0 | -930.0 | -848.0 | -786.0 | -707.0 | -640.0 |
Gross margin | -50.1% | -45.3% | -40.5% | -37.8% | -32.1% | -28.6% | -25.1% | -22.7% |
Selling, general and administrative [+] | 2,260.0 | 2,640.0 | 3,064.0 | 3,555.0 | 3,818.0 | 3,858.0 | 3,821.0 | 3,629.0 |
Sales and marketing | 2,260.0 | 2,640.0 | 3,064.0 | 3,555.0 | 3,818.0 | 3,858.0 | 3,821.0 | 3,629.0 |
Equity in earnings | -30.0 | | -15.0 | | 53.0 | 53.0 | 64.0 | 60.0 |
Other operating expenses | -4,704.0 | -4,616.0 | -4,638.0 | -6,197.0 | -6,834.0 | -7,817.0 | -8,427.0 | -8,019.0 |
EBITDA [+] | 1,426.0 | 1,010.0 | 639.0 | 1,738.0 | 2,221.0 | 3,226.0 | 3,963.0 | 3,810.0 |
EBITDA growth | -35.8% | -68.7% | -83.9% | -54.4% | -41.6% | 5.5% | 82.6% | 99.5% |
EBITDA margin | 72.2% | 48.2% | 28.1% | 70.7% | 84.1% | 117.2% | 140.5% | 135.2% |
Depreciation and amortization | 438.0 | 407.0 | 388.0 | 471.0 | 592.0 | 577.0 | 645.0 | 647.0 |
EBIT [+] | 988.0 | 603.0 | 251.0 | 1,267.0 | 1,629.0 | 2,649.0 | 3,318.0 | 3,163.0 |
EBIT growth | -39.3% | -77.2% | -92.4% | -59.9% | -50.7% | 1.0% | 77.1% | 88.8% |
EBIT margin | 50.1% | 28.8% | 11.0% | 51.5% | 61.7% | 96.2% | 117.6% | 112.2% |
Non-recurring items | 142.0 | -630.0 | -1,599.0 | -1,239.0 | -1,393.0 | -352.0 | 121.0 | -274.0 |
Interest expense | 139.0 | 127.0 | 115.0 | 120.0 | 119.0 | 116.0 | 114.0 | 111.0 |
Interest expense | 139.0 | 127.0 | 115.0 | 120.0 | 119.0 | 116.0 | 114.0 | 111.0 |
Other income (expense), net | | -4.0 | | | | -3.0 | | |
Pre-tax income | 703.0 | 1,102.0 | 1,732.0 | 2,383.0 | 2,900.0 | 2,882.0 | 3,083.0 | 3,326.0 |
Income taxes | 183.0 | 295.0 | 437.0 | 631.0 | 729.0 | 703.0 | 713.0 | 683.0 |
Tax rate | 26.0% | | | 26.5% | 25.1% | 24.4% | 23.1% | 20.5% |
Minority interest | 3.0 | -15.0 | 16.0 | 19.0 | 19.0 | 18.0 | 20.0 | 19.0 |
Earnings from continuing ops | 517.0 | 835.0 | 1,294.0 | 1,759.0 | 2,205.0 | 2,214.0 | 2,414.0 | 3,492.0 |
Earnings from discontinued ops | | | | | | | | 6.0 |
Net income | 517.0 | 835.0 | 1,294.0 | 1,759.0 | 2,202.0 | 2,217.0 | 2,422.0 | 3,498.0 |
Net margin | 26.2% | 39.8% | 57.0% | 71.5% | 83.4% | 80.5% | 85.9% | 124.1% |
|
Basic EPS [+] | $1.90 | $3.05 | $4.68 | $6.30 | $7.83 | $7.80 | $8.45 | $12.23 |
Growth | -75.7% | -60.9% | -44.7% | -48.5% | -37.1% | -33.2% | -11.0% | 143.2% |
Diluted EPS [+] | $1.89 | $3.03 | $4.65 | $6.26 | $7.78 | $7.75 | $8.39 | $12.15 |
Growth | -75.7% | -60.9% | -44.6% | -48.5% | -37.0% | -33.2% | -11.2% | 143.2% |
|
Dividends per share [+] | $1.34 | $1.33 | $1.32 | $1.32 | $1.28 | $1.20 | $1.12 | $1.12 |
Growth | 4.7% | 10.8% | 17.9% | 17.9% | 21.9% | 17.6% | 13.1% | 13.1% |
|
Shares outstanding (basic) [+] | 272.0 | 274.0 | 276.8 | 279.3 | 281.8 | 283.8 | 285.8 | 285.5 |
Growth | -3.5% | -3.4% | -3.1% | -2.2% | -2.0% | -0.5% | 1.5% | 2.4% |
Shares outstanding (diluted) [+] | 273.5 | 275.5 | 278.5 | 281.0 | 283.5 | 285.8 | 287.8 | 287.5 |
Growth | -3.5% | -3.6% | -3.2% | -2.3% | -2.1% | -0.5% | 1.7% | 2.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|